Literature DB >> 19836639

Life expectancy in Alzheimer's disease (AD).

O Zanetti1, S B Solerte, F Cantoni.   

Abstract

Survival following a diagnosis of AD is important information for health planners, caregivers, patients, and their families. AD is associated with variable, but shortened life expectancy. Knowing the expected survival time may empower people with AD and their families, but clinicians currently have limited predictive information. A better knowledge about prognosis in patients affected by AD and related disorders should be of paramount importance in order to improve care plans and assist in medical decisions, above all for patients in the moderate-severe stages of the disease. Life expectancy for patients with AD can vary between 3 to 10 years. Many studies have tried to identify predictive factors that can be of help for clinicians. The main predictor of life expectancy is the age. Therefore caregivers, patients, and their families could plan on a median life span as long as 7 to 10 years for patients whose conditions are diagnosed when they are in their 60s and early 70s, to only about 3 years or less for patients whose conditions are diagnosed when they are in their 90s. Dementias with prominent psychiatric-behavioral manifestations and gait impairment have a faster progression compared to AD. However the many variables that influence life expectancy make difficult to define prognosis at the bedside and more studies are needed to assist clinicians in they daily routine with patients and caregivers.

Entities:  

Mesh:

Year:  2009        PMID: 19836639     DOI: 10.1016/j.archger.2009.09.035

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  31 in total

1.  Clinicians' Perspectives on Barriers and Enablers of Optimal Prescribing in Patients with Dementia and Coexisting Conditions.

Authors:  Ariel R Green; Patricia Lee; Emily Reeve; Jennifer L Wolff; Chi Chiung Grace Chen; Rachel Kruzan; Cynthia M Boyd
Journal:  J Am Board Fam Med       Date:  2019 May-Jun       Impact factor: 2.657

Review 2.  The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.

Authors:  Russell H Swerdlow; Jeffrey M Burns; Shaharyar M Khan
Journal:  Biochim Biophys Acta       Date:  2013-09-23

Review 3.  'Evolutionary medicine' perspectives on Alzheimer's Disease: Review and new directions.

Authors:  Molly Fox
Journal:  Ageing Res Rev       Date:  2018-07-27       Impact factor: 10.895

4.  Use of health and social care services in a cohort of Italian dementia patients.

Authors:  Silvia Scalmana; Anteo Di Napoli; Francesco Franco; Nicola Vanacore; Domenico Di Lallo; Maria Letizia Giarrizzo; Gabriella Guasticchi
Journal:  Funct Neurol       Date:  2013 Oct-Dec

5.  End-of-life care for persons with advanced Alzheimer disease: design and baseline data from the ALFINE study.

Authors:  F Nourhashémi; S Gillette; C Cantet; A Stilmunkes; N Saffon; M E Rougé-Bugat; B Vellas; Y Rolland
Journal:  J Nutr Health Aging       Date:  2012-05       Impact factor: 4.075

6.  The average lifespan of patients discharged from hospital with heart failure.

Authors:  David A Alter; Dennis T Ko; Jack V Tu; Therese A Stukel; Douglas S Lee; Andreas Laupacis; Alice Chong; Peter C Austin
Journal:  J Gen Intern Med       Date:  2012-05-02       Impact factor: 5.128

7.  Launching 'Namaste Care' in Canada: findings from training sessions and initial perceptions of an end-of-life programme for people with advanced dementia.

Authors:  Sharon Kaasalainen; Paulette V Hunter; Courtney Hill; Rachel Moss; Joy Kim; Jenny T van der Steen; Vanina Dal-Bello Haas; Thomas Hadjistavropoulos
Journal:  J Res Nurs       Date:  2019-09-06

8.  Prediction of Alzheimer's disease and mild cognitive impairment using cortical morphological patterns.

Authors:  Chong-Yaw Wee; Pew-Thian Yap; Dinggang Shen
Journal:  Hum Brain Mapp       Date:  2012-08-28       Impact factor: 5.038

9.  Alzheimer disease and cancer risk: a meta-analysis.

Authors:  Hai-bin Shi; Bo Tang; Yao-Wen Liu; Xue-Feng Wang; Guo-Jun Chen
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-12       Impact factor: 4.553

10.  Group-constrained sparse fMRI connectivity modeling for mild cognitive impairment identification.

Authors:  Chong-Yaw Wee; Pew-Thian Yap; Daoqiang Zhang; Lihong Wang; Dinggang Shen
Journal:  Brain Struct Funct       Date:  2013-03-07       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.